Home » Healthcare » Chemiluminescence Immunoassay (CLIA) Market

Chemiluminescence Immunoassay (CLIA) Market By Product Type (Analyzers, Reagents, Others) By Application (Autoimmune Diseases, Endocrine Disorders, Others) By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Clinical Laboratories, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 19265 | Report Format : PDF

Key Highlights of the Report

The global chemiluminescence immunoassay (CLIA) market is segmented by product type, application, end-user, and region. The reagents among the product type segment are the most popular, while endocrine disorders hold the dominant position among the application segment in the chemiluminescence immunoassay (CLIA) market. The hospital and clinical laboratories have the largest market share for the end-user segment, and it holds the dominant position, with North America leading the market growth.

The growth of the global chemiluminescence immunoassay (CLIA) market is propelled by multiple factors, such as the rising incidence of chronic and acute diseases, alongside a notable trend of innovative advancements in diagnostic technologies. Nevertheless, challenges, including a shortage of skilled professionals and stringent government regulations, are expected to impede market growth throughout the forecast period.

Nonetheless, the global chemiluminescence immunoassay (CLIA) market offers significant growth opportunities, such as the increase in the use of chemiluminescence immunoassay in the identification of chronic illnesses such as obesity, infectious diseases, diabetes, autoimmune and cardiovascular diseases. However, the market is driven by two significant factors: increased medication discovery and development efforts by pharmaceutical companies and the growing recognition of the significance of early detection in chronic diseases. These factors are considered major drivers of the market.

What Are the Main Drivers of The Global Chemiluminescence Immunoassay (CLIA) Market?

The global chemiluminescence immunoassay (CLIA) market is driven by several factors, including the rising prevalence of chronic and acute diseases is expected to drive the market growth over the forecast period.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

What Are the Major Challenges of The Global Chemiluminescence Immunoassay (CLIA) Market Faces?

The global chemiluminescence immunoassay (CLIA) market also faces several challenges; the lack of skilled professionals and strict government regulations will hamper the market growth over the forecast period.

What Are the Growth Opportunities in The Global Chemiluminescence Immunoassay (CLIA) Market?

The global chemiluminescence immunoassay (CLIA) market offers significant growth opportunities, such as the increase in the use of chemiluminescence immunoassay in the identification of chronic illnesses such as obesity, infectious diseases diabetes, autoimmune and cardiovascular diseases is expected to drive the market growth over the forecast period.

Executive Summary

Overview of the Global Chemiluminescence Immunoassay (CLIA) Market

The global chemiluminescence immunoassay (CLIA) market has rapidly grown in recent years. People and healthcare professionals are becoming more aware of the value of early diagnosis for chronic illnesses. Timely detection of chronic conditions such as cardiovascular disorders, diabetes, and cancer can significantly improve treatment outcomes and patient survival rates. This awareness has increased demand for advanced diagnostic technologies, including those based on chemiluminescence immunoassay (CLIA), which can provide rapid and accurate results for early disease detection.

Market Definition

Chemiluminescence refers to light emission from a chemical reaction without generating substantial heat. In Chemiluminescence immunoassay, a molecule capable of emitting light during a chemical reaction is attached to both the antigen and antibody. The resulting light emitted is observed and quantified to detect the presence of the antigen-antibody complex.

Market Insights

  • The global demand for chemiluminescence immunoassay (CLIA) was valued at USD 6.1 Billion in 2022 and is expected to reach USD 9.66 Billion in 2030, growing at a CAGR of 6.80% between 2023 and 2030.
  • Reagents is the leading segment and held around half of the share in terms of value in 2022
  • Endocrine disorders among the application exhibit the fastest growing CAGR during the forecast period.
  • Hospital & clinical laboratories are expected to post the highest CAGR during the forecast period & leading the market share with more than 45% share in 2022.
  • Pharmaceutical and biotechnological companies hold the highest growing segment among the adapter type over the forecast period.
  • North America is fuelling the growth of chemiluminescence immunoassay (CLIA), the industry with nearly a two-fifth share in 2022. Europe and Asia Pacific collectively accounted for just under 55% share in 2022. Asia-pacific held over 22% share in 2022.
  • Several factors drive the market for chemiluminescence immunoassay (CLIA). The increasing availability of reimbursement coverage for CLIA-based tests in many healthcare systems encourages their adoption and utilization. Favorable reimbursement policies drive market growth by reducing financial barriers and ensuring wider access to CLIA testing.

Market Overview

The global chemiluminescence immunoassay (CLIA) market has witnessed steady growth in recent years and is expected to grow at a CAGR of 6.80% between 2023 and 2030. In 2022, the market reached a valuation of USD 6.1 billion, projected to grow to USD 9.66 billion by 2030.

Segmentation by Product Type

  • Reagents is the leading segment and held the highest share in value in 2022.
  • The analyzers likely exhibit the fastest CAGR during the forecast period.

Segmentation by Application

  • Endocrine products are the leading segment among the application type
  • While autoimmune disorders held the largest revenue share in 2022, it is expected to hold the fastest CAGR during the forecast period.

Segmentation by End-user

  • The hospitals and clinical laboratories segment governs the demand for chemiluminescence immunoassay (CLIA) in the industry in world, holding a massive share, and is also expected to grow at a rapid CAGR.
  • The pharmaceutical and biotechnological laboratories segment contributes the rest to the demand for chemiluminescence immunoassay (CLIA) in the market.

Segmentation by Region

  • North America was fuelling the growth of chemiluminescence immunoassay (CLIA), the industry with a nearly two-fifths share in 2022.
  • Europe and Asia-pacific collectively account for nearly under 55% share in 2022, with Asia-pacific holding over 22% share in the same year.
  • The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for chemiluminescence immunoassay (CLIA).

Various pharmaceutical companies across the globe are actively engaged in drug discovery and development activities to address the rising burden of chronic diseases globally. Increasing focus is being placed on developing innovative therapeutic solutions to effectively manage and treat these conditions. Chemiluminescence immunoassay plays a crucial role in drug discovery and development by enabling the detection and quantification of biomarkers, which are essential for assessing the efficacy and safety of new drugs during clinical trials. The use of CLIA in pharmaceutical research and development has increased significantly, driving the demand for CLIA technologies and contributing to market growth.

In the US, the increasing cases of chronic and cardiovascular diseases across the country are expected to drive the chemiluminescence immunoassay (CLIA) market. For instance, according to the American Academy of Dermatology Association report, in January 2023, over one million individuals in the United States live with melanoma, a type of skin cancer. The anticipated number of newly diagnosed melanoma cases in the country for 2022 is approximately 197,700. Among these cases, 97,920 are expected to be non-invasive (in situ) melanomas, while 99,780 are projected to be invasive. Regarding cancer diagnoses, invasive melanoma is predicted to rank as the fifth most commonly diagnosed cancer in 2022, with 57,180 cases for men and 42,600 cases for women. Notably, melanoma incidence has started to decrease among adolescents and individuals aged 30 and younger. Conversely, older age groups have experienced increased melanoma incidence, with the most significant increases observed in individuals aged 80 and above.

In China, the approvals by the government body for the acceptance of chemiluminescence immunoassay (CLIA) are expected to drive the market growth for orthopedic braces and support across the country over the forecast period. For instance, in December 2022, ZECEN Biotech has recently obtained the registration certificate from the Chinese registration authorities NMPA. This signifies that their product has obtained the necessary approval for sales in China. The TPS CLIA will be accessible on the Chinese market starting early next year. Furthermore, ZECEN Biotech anticipates receiving regulatory approval for TPS CLIA on Fosun Diagnostics’ fully automated CLIA platforms within the upcoming year.

The expanding global market for Chemiluminescence immunoassay is driven by the increasing prevalence of chronic and acute diseases globally. This diagnostic technique’s accuracy, speed, and versatility make it a crucial tool in disease detection and monitoring, driving its adoption and market growth.

Market Drivers

Several factors drive the global orthopedic braces and support market. The following are the key drivers of the global Chemiluminescence Immunoassay (CLIA) market:

Rising Prevalence of Chronic and Acute Diseases

Chemiluminescence immunoassay (CLIA) is a diagnostic technique that combines the principles of chemiluminescence and immunochemical reactions. Like other labeled immunoassays such as RIA, FIA, and ELISA, CLIA employs chemical probes that can produce light emission through a chemical reaction to label the antibody. Chemiluminescence immunoassay has emerged as a valuable diagnostic technique in detecting and monitoring these diseases. Its high sensitivity, specificity, and ability to see multiple analytes simultaneously make it a preferred choice for healthcare professionals. The increased adoption of Chemiluminescence immunoassay can be attributed to several factors. The method offers rapid and accurate results, enabling timely diagnosis and effective treatment planning. Early detection and intervention are crucial in managing chronic diseases, as they can greatly enhance patient outcomes.

Thus, the significant growth in chronic and acute diseases across the globe is expected to drive the market for Chemiluminescence immunoassay over the forecast period. For instance, according to the report presented by the U.S. Centers for Disease Control and Prevention, in June 2020, 2018, A significant proportion of adults, specifically 51.8%, were diagnosed with at least one of the ten selected chronic conditions. These conditions include arthritis, cancer, chronic obstructive pulmonary disease (COPD), coronary heart disease, current asthma, diabetes, hepatitis, hypertension, stroke, and weak or failing kidneys. Additionally, 27.2% of adults in the United States were found to have multiple chronic conditions, indicating a substantial burden of co-existing health issues among the population.

Rapid Growth in the Technological Advancements in the Chemiluminescence Immunoassay (CLIA) Analyzers

The Chemiluminescence Immunoassay (CLIA) market is experiencing significant growth, primarily due to the rapid advancements in technology within CLIA analyzers. These technological breakthroughs drive the adoption and utilization of CLIA as a preferred diagnostic technique. The continuous growth in technological advances has revolutionized CLIA analyzers, enhancing their performance, accuracy, and efficiency. These advancements have led to the developing of highly sophisticated and automated CLIA systems that offer improved sensitivity and specificity in detecting and quantifying analytes of interest. Integrating advanced chemistries, reagents, and detection methods has significantly enhanced assay performance, enabling the detection of a wider range of diseases and conditions.

Thus, increasing innovations and launch in the Chemiluminescence Immunoassay is expected to drive the global chemiluminescence immunoassay market globally over the forecast period. For instance, in October 2022, Era Biology introduced a novel product line of a Chemiluminescence Immunoassay (CLIA) detection kit. This kit is specifically designed for the identification of inflammation and bacterial infections. The detection kit is compatible with the Full-Automatic Chemiluminescence Immunoassay System (FACIS), offering fast and dependable quantitative results in just one hour. With its fully automated operational steps and user-friendly software, the FACIS system provides a comprehensive solution for various diagnostic applications, including diagnosing invasive fungal diseases. Equipped with the latest technology, the FACIS platform delivers efficient and accurate results, improving patient care.

Market Restraints

The global chemiluminescence immunoassay (CLIA) market faces challenges that may hinder its growth. These include the following:

Government Regulations That Are Strict And The Lack Of Skilled Professionals

Scarcity of skilled professionals who are proficient in operating and interpreting CLIA systems. CLIA technology requires specialized knowledge and expertise to ensure accurate and reliable results. However, there is a need for more trained laboratory technicians and healthcare professionals with the necessary skills and experience to perform CLIA tests effectively. The limited availability of skilled professionals poses a significant barrier to the widespread adoption and utilization of CLIA in healthcare settings.

Moreover, strict government regulations and compliance requirements present obstacles to the growth of the CLIA market. Regulatory agencies impose stringent guidelines and standards to ensure diagnostic tests’ quality, safety, and efficacy, including CLIA assays. These regulations are necessary to safeguard patient health and maintain the integrity of laboratory testing.

Opportunities

The global chemiluminescence immunoassay (CLIA) market offers significant growth opportunities. These include the following:

Increase in The Use of Chemiluminescence Immunoassay in The Identification of Chronic Illnesses Such as Obesity, Infectious Diseases Diabetes, Autoimmune and Cardiovascular Diseases

CLIA has emerged as a valuable diagnostic tool due to its specificity, high sensitivity, and accuracy in detecting biomarkers associated with chronic illnesses. In the case of obesity, CLIA allows for measuring specific biomarkers related to metabolic disorders, providing insights into the underlying mechanisms and assisting in personalized treatment approaches.

CLIA is crucial in identifying specific antigens or antibodies associated with various pathogens in infectious diseases. Its ability to provide rapid and accurate results aids in early detection, effective treatment, and containment of infectious diseases, contributing to improved patient outcomes and public health management. The high sensitivity, specificity, and ability to quantify a wide range of biomarkers make CLIA a preferred choice for healthcare professionals in various clinical settings. As a result, the demand for CLIA systems, reagents, and related technologies is experiencing substantial growth, driving the expansion of the CLIA market. The increasing launch of CLIA systems for detecting such diseases is expected to drive market growth over the forecast period. For instance, in November 2022,  Getein Biotech, Inc., a global biotechnology company, announced the launch of its cutting-edge product lineup, including the MAGICL 6000. This compact and innovative chemiluminescence immunoassay analyzer is ideally suited for mid to high-workflow laboratories seeking a streamlined chemiluminescence solution. With its exceptional productivity and compact design, this instrument offers fully automated operation and boasts the fastest testing speed among devices of similar size.

Competitive Landscape

Key Players

The global chemiluminescence immunoassay (CLIA) market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Hoffmann-La Roche AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Danaher (Beckman Coulter Inc.)
  • DiaSorin S.p.A.
  • Sysmex Corporation
  • Randox Laboratories Ltd.
  • Tosoh Corporation
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • BioMerieux

These companies focus on product innovation, expanding their braces and support types, mergers, and acquisitions to stay ahead in the market.

The major players in the global chemiluminescence immunoassay (CLIA) market constantly strive to stay ahead by introducing new products and innovations.

In April 2023, Fapon Biotech Inc. unveiled its innovative strategy for a comprehensive chemiluminescence one-stop solution at the 28th edition of Medical Fair India. The Fapon chemiluminescence one-stop solution is specifically designed to offer a complete range of products and services related to chemiluminescence technology. This includes a variety of fully automatic chemiluminescence analyzers with open system platforms, support for reagent development, and the provision of high-quality core raw materials for bulk production.

In June 2022, Roche, a Switzerland-based biotechnology company, introduced its latest state-of-the-art tissue staining platform, the BenchMark ULTRA PLUS system. This advanced instrument is designed to automate the staining process of histological or cytological specimens on microscopic slides using specific immunohistochemistry, immunocytochemistry, or in situ hybridization reagents for in vitro diagnostic (IVD) applications. The BenchMark ULTRA PLUS system offers enhanced efficiency and precision in the staining procedure, providing accurate and reliable results for diagnostic purposes. With this innovative technology, Roche continues to advance the field of diagnostic pathology, supporting healthcare professionals in their quest for accurate and timely diagnoses.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The rapid growth in the technological advancements in the chemiluminescence immunoassay analyzers across the globe has spurred the global chemiluminescence immunoassay (CLIA) market.
  • Market segmented by product type, application, end-user, and region.
  • Reagents are the most popular segment in the product type types
  • Analyzers among the product type segment are expected to put the highest CAGR over the forecast period
  • Among the application segment, endocrine disorders holds the highest market share across the globe
  • Hospitals and clinical laboratories are the most popular segment among the end-user
  • While pharmaceutical and biotechnology companies among the end-use segment are expected to put the highest CAGR over the forecast period
  • North America is leading market growth. The market is highly competitive with key players, including Danaher (Beckman Coulter Inc.).

Future Outlook

  • Positive outlook for the global chemiluminescence immunoassay (CLIA) market with significant growth potential in the North American region
  • The increasing prevalence of orthopedic diseases and disorders across the globe is driving the market growth for orthopedic braces and support
  • Challenges such as the lack of skilled professionals and strict government regulations are expected to hamper the market growth. As the market expands, efforts are needed to develop cost-effective solutions without compromising safety and quality. Manufacturers must balance affordability and functionality to cater to a wide range of customers.

Segmentation

  • By Product Type
    • Analyzers
    • Reagents
    • Others
  • By Application
    • Autoimmune Diseases
    • Endocrine Disorders
    • Others
  • By End-user
    • Pharmaceutical and Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Others
  • By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Chemiluminescence Immunoassay CLIA Market
2.2. Global Chemiluminescence Immunoassay CLIA Market, By Product Type
2.3. Global Chemiluminescence Immunoassay CLIA Market, By Application
2.4. Global Chemiluminescence Immunoassay CLIA Market, By End User
2.5. Global Chemiluminescence Immunoassay CLIA Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Chemiluminescence Immunoassay CLIA Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Application
3.5.3. End User
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Product Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Chemiluminescence Immunoassay CLIA Market, By Product Type
7.1. Global Chemiluminescence Immunoassay CLIA Market Overview, by Product Type
7.1.1. Global Chemiluminescence Immunoassay CLIA Market Revenue Share, By Product Type, 2022 Vs 2030 (in %)
7.2. Analyzers
7.2.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
7.3. Reagents
7.3.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
7.4. Consumables
7.4.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)

8. Global Chemiluminescence Immunoassay CLIA Market, By Application
8.1. Global Chemiluminescence Immunoassay CLIA Market Overview, by Application
8.1.1. Global Chemiluminescence Immunoassay CLIA Market Revenue Share, By Application, 2022 Vs 2030 (in %)
8.2. Oncology
8.2.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
8.3. Autoimmune Disorder
8.3.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
8.4. Infectious Disease
8.4.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
8.5. Cardiovascular Disease
8.5.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
8.6. Endocrine Disease
8.6.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
8.7. Others
8.7.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)

9. Global Chemiluminescence Immunoassay CLIA Market, By End User
9.1. Global Chemiluminescence Immunoassay CLIA Market Overview, By End User
9.1.1. Global Chemiluminescence Immunoassay CLIA Market Revenue Share, By End User, 2022 Vs 2030 (in %)
9.2. Pharmaceutical and Biotechnology Companies
9.2.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
9.3. Hospital and Clinical Laboratories
9.3.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)
9.4. Others
9.4.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2017-2030 (US$ Bn)

10. Global Chemiluminescence Immunoassay CLIA Market, By Region
10.1. Global Chemiluminescence Immunoassay CLIA Market Overview, by Region
10.1.1. Global Chemiluminescence Immunoassay CLIA Market, By Region, 2022 vs 2030 (in%)
10.2. Product Type
10.2.1. Global Chemiluminescence Immunoassay CLIA Market, By Product Type, 2017-2030 (US$ Bn)
10.3. Application
10.3.1. Global Chemiluminescence Immunoassay CLIA Market, By Application, 2017-2030 (US$ Bn)
10.4. End Users
10.4.1. Global Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030 (US$ Bn)

11. North America Chemiluminescence Immunoassay CLIA Market Analysis
11.1. North America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Chemiluminescence Immunoassay CLIA Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
11.4.3.3. Canada Chemiluminescence Immunoassay CLIA, By Application Type, 2017-2030 (US$ Bn)
11.4.3.4. Canada Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)

12. Europe Chemiluminescence Immunoassay CLIA Market Analysis
12.1. Europe Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2030(US$ Bn)/
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2030 (US$ Bn)
12.4.1. Europe Chemiluminescence Immunoassay CLIA Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.2.3. Germany Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.2.4. Germany Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.3.3. France Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.3.4. France Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.4.3. UK Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.4.4. UK Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.5.3. Italy Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.5.4. Italy Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.6.3. Spain Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.6.4. Spain Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)

13. Asia Pacific Chemiluminescence Immunoassay CLIA Market Analysis
13.1. Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.2.3. China Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.2.4. China Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.3.3. Japan Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.3.4. Japan Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.4.3. India Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.4.4. India Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)

14. Latin America Chemiluminescence Immunoassay CLIA Market Analysis
14.1. Latin America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Chemiluminescence Immunoassay CLIA Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)

15. Middle East and Africa Chemiluminescence Immunoassay CLIA Market Analysis
15.1. Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA, By Product Type, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA, By Application, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA, By End User, 2017-2030 (US$ Bn)

16. Company Profiles
16.1. F. Hoffmann-La Roche AG
16.1.1. Company Overview
16.1.2. Product /Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. F. Hoffmann-La Roche AG
16.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.4. Siemens Healthineers AG
16.5. Danaher (Beckman Coulter Inc.)
16.6. DiaSorin S.p.A.
16.7. Sysmex Corporation
16.8. Randox Laboratories Ltd.
16.9. Tosoh Corporation
16.10. Shenzhen New Industries Biomedical Engineering Co., Ltd.
16.11. BioMerieux

List of Figures
FIG. 1 Global Chemiluminescence Immunoassay CLIA Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Chemiluminescence Immunoassay CLIA Market Segmentation
FIG. 4 Global Chemiluminescence Immunoassay CLIA Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Chemiluminescence Immunoassay CLIA Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Chemiluminescence Immunoassay CLIA Market, By End User, 2022 (US$ Bn)
FIG. 7 Global Chemiluminescence Immunoassay CLIA Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Product Type, 2022
FIG. 9 Attractive Investment Proposition, by Application, 2022
FIG. 10 Attractive Investment Proposition, By End User, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Chemiluminescence Immunoassay CLIA Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Chemiluminescence Immunoassay CLIA Market Manufacturers, 2022
FIG. 14 Global Chemiluminescence Immunoassay CLIA Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 15 Global Chemiluminescence Immunoassay CLIA Market, by Analyzers, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Chemiluminescence Immunoassay CLIA Market, by Reagents, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Chemiluminescence Immunoassay CLIA Market, by Consumables, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Chemiluminescence Immunoassay CLIA Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 19 Global Chemiluminescence Immunoassay CLIA Market, by Oncology, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Chemiluminescence Immunoassay CLIA Market, by Autoimmune Disorder, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Chemiluminescence Immunoassay CLIA Market, by Infectious Disease, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Chemiluminescence Immunoassay CLIA Market, by Cardiovascular Disease, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Chemiluminescence Immunoassay CLIA Market, by Endocrine Disorders, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Chemiluminescence Immunoassay CLIA Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Chemiluminescence Immunoassay CLIA Market, by End User, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Chemiluminescence Immunoassay CLIA Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Chemiluminescence Immunoassay CLIA Market Value Contribution, By Hospital and Clinical Laboratories, 2022 & 2030 (Value %)
FIG. 28 Global Chemiluminescence Immunoassay CLIA Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 29 North America Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 30 U.S. Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 31 Canada Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 32 Europe Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 33 Germany Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 34 France Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 35 U.K. Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 36 Italy Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 37 Spain Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Europe Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 39 Asia Pacific Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 40 China Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 41 Japan Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 42 India Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 43 South Korea Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 44 South-East Asia Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 46 Latin America Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 47 Brazil Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 50 Middle East & Africa Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 51 GCC Countries Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 52 South Africa Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Chemiluminescence Immunoassay CLIA Market
TABLE 2 Global Chemiluminescence Immunoassay CLIA Market: Market Drivers Impact Analysis
TABLE 3 Global Chemiluminescence Immunoassay CLIA Market: Market Restraints Impact Analysis
TABLE 4 Global Chemiluminescence Immunoassay CLIA Market, by Competitive Benchmarking, 2022
TABLE 5 Global Chemiluminescence Immunoassay CLIA Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Chemiluminescence Immunoassay CLIA Market, by Key Strategies Analysis, 2022
TABLE 7 Global Chemiluminescence Immunoassay CLIA Market, by Analyzers, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Chemiluminescence Immunoassay CLIA Market, by Analyzers, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Chemiluminescence Immunoassay CLIA Market, by Reagents, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Chemiluminescence Immunoassay CLIA Market, by Reagents, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Chemiluminescence Immunoassay CLIA Market, by Analyzers, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Chemiluminescence Immunoassay CLIA Market, by Analyzers, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Chemiluminescence Immunoassay CLIA Market, by Reagents, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Chemiluminescence Immunoassay CLIA Market, by Reagents, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Chemiluminescence Immunoassay CLIA Market, by Consumables, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Chemiluminescence Immunoassay CLIA Market, by Consumables, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Chemiluminescence Immunoassay CLIA Market, by Oncology, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Chemiluminescence Immunoassay CLIA Market, by Oncology, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Chemiluminescence Immunoassay CLIA Market, by Autoimmune Disorder, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Chemiluminescence Immunoassay CLIA Market, by Autoimmune Disorder, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Chemiluminescence Immunoassay CLIA Market, by Infectious Disease, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Chemiluminescence Immunoassay CLIA Market, by Infectious Disease, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Chemiluminescence Immunoassay CLIA Market, by Cardiovascular Disease, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Chemiluminescence Immunoassay CLIA Market, by Cardiovascular Disease, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Chemiluminescence Immunoassay CLIA Market, by Endocrine Disorder, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Chemiluminescence Immunoassay CLIA Market, by Endocrine Disorder, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Chemiluminescence Immunoassay CLIA Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Chemiluminescence Immunoassay CLIA Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Chemiluminescence Immunoassay CLIA Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Chemiluminescence Immunoassay CLIA Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Chemiluminescence Immunoassay CLIA Market, by Hospital and Clinical Laboratories, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Chemiluminescence Immunoassay CLIA Market, by Hospital and Clinical Laboratories, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Chemiluminescence Immunoassay CLIA Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Chemiluminescence Immunoassay CLIA Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 36 Global Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 37 Global Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 38 Global Chemiluminescence Immunoassay CLIA Market, by Region, 2017-2022 (US$ Bn)
TABLE 39 Global Chemiluminescence Immunoassay CLIA Market, by Region, 2023-2030 (US$ Bn)
TABLE 40 North America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 41 North America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 42 North America Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 43 North America Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 44 North America Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 45 North America Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 46 North America Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2022 (US$ Bn)
TABLE 47 North America Chemiluminescence Immunoassay CLIA Market, by Country, 2023-2030 (US$ Bn)
TABLE 48 United States Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 49 United States Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 50 United States Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 51 United States Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 52 United States Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 53 United States Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 54 Canada Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 55 Canada Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 56 Canada Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 57 Canada Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 58 Canada Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 59 Canada Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 60 Mexico Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 61 Mexico Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 62 Mexico Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 63 Mexico Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 64 Mexico Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 65 Mexico Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 66 vehicEurope Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 67 Europe Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 68 Europe Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 69 Europe Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 70 Europe Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 71 Europe Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 72 Europe Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2022 (US$ Bn)
TABLE 73 Europe Chemiluminescence Immunoassay CLIA Market, by Country, 2023-2030 (US$ Bn)
TABLE 74 Germany Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 75 Germany Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 76 Germany Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 77 Germany Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 78 Germany Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 79 Germany Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 80 France Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 81 France Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 82 France Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 83 France Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 84 France Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 85 France Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 86 United Kingdom Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 87 United Kingdom Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 88 United Kingdom Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 89 United Kingdom Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 90 United Kingdom Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 91 United Kingdom Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 92 Italy Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 93 Italy Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 94 Italy Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 95 Italy Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 96 Italy Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 97 Italy Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 98 Spain Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 99 Spain Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 100 Spain Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 101 Spain Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 102 Spain Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 103 Spain Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 104 Rest of Europe Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 105 Rest of Europe Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 106 Rest of Europe Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 107 Rest of Europe Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 108 Rest of Europe Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 109 Rest of Europe Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 110 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 111 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 112 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 113 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 114 Asia Pacific Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 115 Asia Pacific Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 116 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2022 (US$ Bn)
TABLE 117 Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Country, 2023-2030 (US$ Bn)
TABLE 118 China Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 119 China Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 120 China Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 121 China Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 122 China Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 123 China Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 124 Japan Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 125 Japan Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 126 Japan Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 127 Japan Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 128 Japan Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 129 Japan Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 130 India Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 131 India Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 132 India Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 133 India Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 134 India Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 135 India Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 136 South Korea Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 137 South Korea Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 138 South Korea Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 139 South Korea Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 140 South Korea Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 141 South Korea Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 142 South-East Asia Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 143 South-East Asia Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 144 South-East Asia Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 145 South-East Asia Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 146 South-East Asia Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 147 South-East Asia Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 148 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 149 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 150 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 151 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 152 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 153 Rest of Asia Pacific Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 154 Latin America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 155 Latin America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 156 Latin America Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 157 Latin America Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 158 Latin America Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 159 Latin America Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 160 Latin America Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2022 (US$ Bn)
TABLE 161 Latin America Chemiluminescence Immunoassay CLIA Market, by Country, 2023-2030 (US$ Bn)
TABLE 162 Brazil Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 163 Brazil Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 164 Brazil Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 165 Brazil Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 166 Brazil Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 167 Brazil Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 168 Argentina Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 169 Argentina Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 170 Argentina Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 171 Argentina Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 172 Argentina Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 173 Argentina Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 174 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 175 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 176 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 177 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 178 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 179 Rest of Latin America Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 180 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 181 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 182 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 183 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 184 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 185 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 186 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Country, 2017-2022 (US$ Bn)
TABLE 187 Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Country, 2023-2030 (US$ Bn)
TABLE 188 GCC Countries Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 189 GCC Countries Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 190 GCC Countries Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 191 GCC Countries Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 192 GCC Countries Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 193 GCC Countries Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 194 South Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 195 South Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 196 South Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 197 South Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 198 South Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 199 South Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)
TABLE 200 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 201 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 202 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2017-2022 (US$ Bn)
TABLE 203 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, by Application, 2023-2030 (US$ Bn)
TABLE 204 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2017-2022 (US$ Bn)
TABLE 205 Rest of Middle East and Africa Chemiluminescence Immunoassay CLIA Market, By End User, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global chemiluminescence immunoassay (CLIA) market?

The global chemiluminescence immunoassay (CLIA) market was valued at USD 6.1 Billion in 2022.

What is the expected growth rate of the chemiluminescence immunoassay (CLIA) market between 2023 and 2030?

The chemiluminescence immunoassay (CLIA) market is expected to grow at a CAGR of 6.80% between 2023 and 2030, reaching USD 9.66 Billion in 2030.

Which product segment is leading the market share in terms of product type?

Reagents are the leading segment by product type, holding around half of the share in value in 2022.

Which application segment governs the global demand for chemiluminescence immunoassay (CLIA)?

The endocrine disorders application segment governs the demand for chemiluminescence immunoassay (CLIA) worldwide, holding a massive share of nearly 45% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

The autoimmune disorder segment will post the highest CAGR during the forecast period.

Which region is fuelling the growth of the chemiluminescence immunoassay (CLIA) industry?

North America is fueling the growth of the chemiluminescence immunoassay (CLIA) industry, with a nearly two-fifth share in 2022.

Who are the major players in the global chemiluminescence immunoassay (CLIA) market?

The top players include F. Hoffmann-La Roche AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Danaher (Beckman Coulter Inc.), DiaSorin S.p.A., Sysmex Corporation, Randox Laboratories Ltd., Tosoh Corporation, Shenzhen New Industries Biomedical Engineering Co., Ltd., BioMerieux and others.

What is the major market driver of the chemiluminescence immunoassay (CLIA) industry?

The increasing prevalence of chronic and acute diseases is expected to drive the demand for chemiluminescence immunoassay (CLIA).

What are the major market restraints of the chemiluminescence immunoassay (CLIA) industry?

The industry needs more skilled professionals and strict government regulations restraint of chemiluminescence immunoassay (CLIA).

What are the major market opportunities of the chemiluminescence immunoassay (CLIA) industry?

The increase in the use of chemiluminescence immunoassay in identifying chronic illnesses such as obesity, infectious diseases, diabetes, and autoimmune and cardiovascular diseases is an opportunity for Chemiluminescence Immunoassay (CLIA) in the industry.

Single Use Upstream Bioprocessing Technology Market

Published:
Report ID: 41061

Viral Clearance and Testing Services Market

Published:
Report ID: 41070

Rare Kidney Diseases Market

Published:
Report ID: 41082

Single Use Bioreactors Market

Published:
Report ID: 41087

Oral Solid Dosage Manufacturing Market

Published:
Report ID: 41090

Plasmid DNA Manufacturing Market

Published:
Report ID: 41100

Nanoparticle Formulation Market

Published:
Report ID: 41106

Next Generation Drug Conjugates Market

Published:
Report ID: 41115

Lab Automation Market

Published:
Report ID: 41013

Sober Living Homes Market

Published:
Report ID: 40991

Radiopharmaceuticals Market

Published:
Report ID: 40978

Aptamers Therapeutics Technologies and Services Market

Published:
Report ID: 40945

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN